We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Artificial Intelligence (AI) Model Identifies COVID-19 Patients Using Blood Tests and Chest X-Rays

By LabMedica International staff writers
Posted on 19 Jul 2021
Print article
Image: Artificial Intelligence (AI) Model Identifies COVID-19 Patients Using Blood Tests and Chest X-Rays (Photo courtesy of Nature)
Image: Artificial Intelligence (AI) Model Identifies COVID-19 Patients Using Blood Tests and Chest X-Rays (Photo courtesy of Nature)
Researchers have developed a machine learning (ML) application for the prediction of SARS-CoV-2 infection using blood tests and chest radiograph.

The ML model developed by researchers at The University of Hong Kong (Hong Kong) was able to achieve high accuracy for the prediction of SARS-CoV-2 infection in a validation study. The adjunctive use of chest radiograph could play a role in increasing sensitivity while achieving moderate specificity when combined with ML blood model, which may have potential implications in triaging patients, particularly when RT-PCR testing resources are scarce.

The objective of this study was to apply ML for the task of COVID-19 detection using basic laboratory markers and explore the adjunctive role of chest radiographs. The researchers initially performed a statistical comparison of blood tests in patients with different aetiologies of pneumonia, including COVID-19 involving 5,148 patients in 24 hospitals in Hong Kong during the first and second waves of infection. This was done to establish a baseline laboratory comparison between COVID-19 from other pneumonia and other diagnoses. The researchers then trained and validated ML models using basic blood tests with comparison to reference RT-PCR testing to predict COVID-19 infection status, and explore different use case scenarios with adjunction of chest radiographs. The models were then validated with temporal validation sets across other waves of infection in Hong Kong.

For predicting SARS-CoV-2 infection, the ML model achieved high AUCs and specificity but low sensitivity in all three validation sets (AUC: 89.9-95.8%; Sensitivity: 55.5-77.8%; Specificity: 91.5-98.3%). When used in adjunction with radiologist interpretations of chest radiographs, the sensitivity was over 90% while keeping moderate specificity. The study showed that ML model based on readily available laboratory markers could achieve high accuracy in predicting SARS-CoV-2 infection.

Related Links:
The University of Hong Kong

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.